View Full Portfolio

ART-SARL

Founded: 2002
Location: France
Status: Series C
Amount Seeking:

About the Company: ART is a leading innovator in the field of the next generation of fully BioResorbable Scaffolds (BRS) that promote the natural remodeling of an injured artery after vascular angioplasty

Visit Company Website


Alios BioPharma

Founded: 2006
Location: San Francisco, CA
Status: IPO
Amount Seeking:

About the Company: In November of 2014, Johnson & Johnson (NYSE: JNJ) announced the completion of the acquisition of Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases. Alios BioPharma is now part of the infectious diseases therapeutic area of the Janssen Pharmaceutical Companies of Johnson & Johnson.  The acquisition includes Alios BioPharma’s portfolio of potential therapeutics for viral infections with the promising compound AL-8176, an orally administered antiviral therapy currently in Phase 2 studies for the treatment of infants with respiratory syncytial virus (RSV).  RSV is the last of the major pediatric diseases that currently has no effective therapy.  The acquisition also includes two early-stage compounds for hepatitis C (HCV).

Visit Company Website


Autonomic Technologies

Founded: 2007
Location: Redwood City, CA / Cleveland, OH
Status: Series D
Amount Seeking:

About the Company: Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company’s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache.

Visit Company Website


Cancer Genetics

Founded: 2013
Location: Rutherford, NJ
Status: IPO
Amount Seeking:

About the Company: Cancer Genetics, Inc. (CGI) is a leader in the field of personalized medicine, offering diagnostic products and services that enable precision medicine in the field of oncology.

Visit Company Website


CardioMEMS

Founded: 2000
Location: Atlanta, GA
Status: Acquired
Amount Seeking:

About the Company: The CardioMEMS™ HF System is the first and only FDA-approved heart failure (HF) monitoring system proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class III patients. Acquired by St. Jude Medical.

Visit Company Website


CardioNomic

Founded: 2007
Location: Cleveland, OH
Status: Series A
Amount Seeking:

About the Company: Cardionomic treats reduced cardiac output – ADHF’s root cause – by neuromodulating the terminal branches of the cardiac plexus to benignly increase contractility.

Visit Company Website


Centerline Biomedical

Founded: 2014
Location: Cleveland, OH
Status: Seed
Amount Seeking: $4M

About the Company: Centerline Biomedical is developing an innovative system to navigate catheters and guide wires (and ultimately devices) in the 3D anatomy of vascular disease patients. This system will empower surgeons to perform safer, more accurate, and more efficient endovascular procedures.

Visit Company Website


ClearFlow, Inc.

Founded: 2007
Location: Anaheim, CA
Status: Series C
Amount Seeking:

About the Company: ClearFlow is a California based medical device company pioneering new technologies to solve the clinical problems associated with obstructed catheters.

ClearFlow was formed from the collaborative efforts of the Cleveland Clinic Foundation and MDI Partners. The company’s product pipeline is based on its proprietary Active Clearance Technology® (ACT) to resolve catheter clogging in multiple medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage.

Visit Company Website


Cleveland BioLabs, Inc.

Founded: 2003
Location: Buffalo, NY
Status: IPO
Amount Seeking:

About the Company: Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells.

Visit Company Website


Cleveland Diagnostics

Founded: 2013
Location: Cleveland, OH
Status: Series A
Amount Seeking: $5M

About the Company: Cleveland Diagnostics is developing a breakthrough technology to discover new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable

Visit Company Website


  < 1 2 3 4 5  >